• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.对巴西一家囊性纤维化中心成年患者气道微生物群的分析。
Braz J Microbiol. 2020 Dec;51(4):1747-1755. doi: 10.1007/s42770-020-00381-3. Epub 2020 Sep 17.
2
Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.成人囊性纤维化患者气道微生物群中的真菌和细菌多样性:传统方法与超深度测序的一致性及其在临床实验室中的实际应用。
Mycopathologia. 2018 Feb;183(1):171-183. doi: 10.1007/s11046-017-0185-x. Epub 2017 Aug 1.
3
Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.囊性纤维化肺部微生物组中包括捕食细菌在内的复杂性的个体模式,在 1 年期间的变化。
mBio. 2017 Sep 26;8(5):e00959-17. doi: 10.1128/mBio.00959-17.
4
Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.不同的下一代测序平台在囊性纤维化痰液中产生不同的微生物谱和多样性。
J Microbiol Methods. 2016 Nov;130:95-99. doi: 10.1016/j.mimet.2016.09.002. Epub 2016 Sep 5.
5
The metabolic footprint of the airway bacterial community in cystic fibrosis.囊性纤维化气道细菌群落的代谢足迹。
Microbiome. 2017 Jun 30;5(1):67. doi: 10.1186/s40168-017-0289-z.
6
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.囊性纤维化气道微生物组在临床稳定期的测量。
Ann Am Thorac Soc. 2019 Dec;16(12):1534-1542. doi: 10.1513/AnnalsATS.201903-270OC.
7
Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.微生物群和代谢物分析揭示了囊性纤维化气道在病情加重期间细菌群落结构和环境的特定变化。
PLoS One. 2013 Dec 17;8(12):e82432. doi: 10.1371/journal.pone.0082432. eCollection 2013.
8
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.囊性纤维化中的气道微生物群:复杂的真菌和细菌群落 - 对治疗管理的影响。
PLoS One. 2012;7(4):e36313. doi: 10.1371/journal.pone.0036313. Epub 2012 Apr 27.
9
Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions.通过 Illumina 测序对囊性纤维化肺部微生物组进行分析。
PLoS One. 2012;7(10):e45791. doi: 10.1371/journal.pone.0045791. Epub 2012 Oct 2.
10
Divergence of bacterial communities in the lower airways of CF patients in early childhood.婴幼儿 CF 患者下呼吸道细菌群落的差异。
PLoS One. 2021 Oct 6;16(10):e0257838. doi: 10.1371/journal.pone.0257838. eCollection 2021.

引用本文的文献

1
Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症的比较微生物组分析。
Respir Res. 2024 May 18;25(1):211. doi: 10.1186/s12931-024-02835-w.
2
Exploring the dynamics of mixed-species biofilms involving Candida spp. and bacteria in cystic fibrosis.探索涉及假丝酵母菌属和细菌的囊性纤维化混合物种生物膜的动态。
Arch Microbiol. 2024 May 11;206(6):255. doi: 10.1007/s00203-024-03967-9.
3
[An updated review of the mechanism of fibrosis in acquired laryngotrachealstenosis].[后天性喉气管狭窄纤维化机制的最新综述]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Apr;36(4):310-314. doi: 10.13201/j.issn.2096-7993.2022.04.016.

本文引用的文献

1
, a potential predictive biomarker of pulmonary infection in cystic fibrosis.中性粒细胞明胶酶相关脂质运载蛋白,囊性纤维化肺部感染的潜在预测性生物标志物。
BMJ Open Respir Res. 2019 Mar 12;6(1):e000374. doi: 10.1136/bmjresp-2018-000374. eCollection 2019.
2
Longitudinal development of the airway microbiota in infants with cystic fibrosis.囊性纤维化婴儿气道微生物组的纵向发育。
Sci Rep. 2019 Mar 26;9(1):5143. doi: 10.1038/s41598-019-41597-0.
3
Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations.微生物组网络和变化点分析揭示了与囊性纤维化肺部恶化相关的关键群落变化。
NPJ Biofilms Microbiomes. 2019 Jan 21;5(1):4. doi: 10.1038/s41522-018-0077-y. eCollection 2019.
4
Airway microenvironment alterations and pathogen growth in cystic fibrosis.气道微环境改变与囊性纤维化中的病原体生长。
Pediatr Pulmonol. 2019 Apr;54(4):497-506. doi: 10.1002/ppul.24246. Epub 2019 Jan 8.
5
Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.气道细菌群落随囊性纤维化临床状态和疾病阶段的波动。
PLoS One. 2018 Mar 9;13(3):e0194060. doi: 10.1371/journal.pone.0194060. eCollection 2018.
6
Airway microbiota across age and disease spectrum in cystic fibrosis.囊性纤维化患者气道微生物组的年龄与疾病谱特征。
Eur Respir J. 2017 Nov 16;50(5). doi: 10.1183/13993003.00832-2017. Print 2017 Nov.
7
Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.26 年随访监测一例囊性纤维化患者的临床和微生物学演变:巴西囊性纤维化中心的经验。
BMC Pulm Med. 2017 Jul 14;17(1):100. doi: 10.1186/s12890-017-0442-2.
8
Lessons from the lower airway microbiome in early CF.早期囊性纤维化下呼吸道微生物组的经验教训。
Thorax. 2017 Dec;72(12):1063-1064. doi: 10.1136/thoraxjnl-2017-210060. Epub 2017 Apr 27.
9
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.早期囊性纤维化肺病患者的下呼吸道微生物组:一项纵向分析。
Thorax. 2017 Dec;72(12):1104-1112. doi: 10.1136/thoraxjnl-2016-209279. Epub 2017 Mar 9.
10
Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.对囊性纤维化患者肺部微生物群进行纵向采样。
PLoS One. 2017 Mar 2;12(3):e0172811. doi: 10.1371/journal.pone.0172811. eCollection 2017.

对巴西一家囊性纤维化中心成年患者气道微生物群的分析。

Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.

作者信息

Leite Cassiana Costa Ferreira, de Freitas Flavia Alvim Dutra, de Cássia Firmida Mônica, Leão Robson Souza, Albano Rodolpho Mattos, Marques Elizabeth Andrade

机构信息

Department of Microbiology, Immunology and Parasitology, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.

Department of Chest Diseases, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Braz J Microbiol. 2020 Dec;51(4):1747-1755. doi: 10.1007/s42770-020-00381-3. Epub 2020 Sep 17.

DOI:10.1007/s42770-020-00381-3
PMID:32944872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7688754/
Abstract

The application of next-generation sequencing tools revealed that the cystic fibrosis respiratory tract is a polymicrobial environment. We have characterized the airway bacterial microbiota of five adult patients with cystic fibrosis during a 14-month period by 16S rRNA tag sequencing using the Illumina technology. Microbial diversity, estimated by the Shannon index, varied among patient samples collected throughout the follow-up period. The beta diversity analysis revealed that the composition of the airway microbiota was highly specific for each patient, showing little variation among the samples of each patient analyzed over time. The composition of the bacterial microbiota did not reveal any emerging pathogen predictor of pulmonary disease in cystic fibrosis or of its unfavorable clinical progress, except for unveiling the presence of anaerobic microorganisms, even without any established clinical association. Our results could potentialy help us to translate and develop strategies in response to the pathobiology of this disease, particularly because it represents an innovative approach for CF centers in Brazil.

摘要

新一代测序工具的应用表明,囊性纤维化患者的呼吸道是一个多种微生物共存的环境。我们使用Illumina技术通过16S rRNA标签测序对5名成年囊性纤维化患者在14个月期间的气道细菌微生物群进行了特征分析。通过香农指数估计的微生物多样性在整个随访期间收集的患者样本中有所不同。β多样性分析表明,气道微生物群的组成对每位患者具有高度特异性,在对每位患者不同时间分析的样本中变化很小。细菌微生物群的组成未揭示囊性纤维化肺部疾病或其不良临床进展的任何新出现的病原体预测指标,只是揭示了厌氧微生物的存在,即使没有任何已确定的临床关联。我们的结果可能有助于我们针对这种疾病的病理生物学转化和制定应对策略,特别是因为这对巴西的囊性纤维化中心来说是一种创新方法。